Search

everythinglearnresearchcommunity

for

Search:↓

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

ALRN-6924 may prevent hair loss caused by chemotherapy.

The document concludes that validated methods are needed to ensure the quality of fluconazole drugs and that new antifungal medications are necessary due to safety and resistance concerns.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

The document's conclusion cannot be provided because the content is not available to parse.

Different lasers and radiofrequency affect skin differently, important for dermatologists to choose the right treatment.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Oral isotretinoin effectively treats yellow facial papules in frontal fibrosing alopecia patients.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Platelet concentrates are useful for tissue repair in medicine and dentistry, with L-PRF showing promising results in various treatments.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Folliculitis decalvans is a rare skin disease causing hair loss and requires personalized treatment.

Using sunscreen and moisturizers may increase the chance of developing Frontal fibrosing alopecia (FFA), but the exact reason why is still unclear.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

The document's content cannot be summarized because it is not accessible or understandable.

QR678 treatments were more effective and comfortable for male hair loss than PRP treatments.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.